Open
SectorHealthcare
448.47 -1.57
24h
Min
446.15
Max
461.19
Income | -8.8M -66M |
---|---|
Sales | 180M 774M |
Profit margin | -8.566 |
Employees | 2,230 |
EBITDA | 7.4M 19M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | -0.09% downside |
Next Earnings | 30 Oct 2025 |
---|
Market Cap | 16B 59B |
---|---|
Previous open | 450.04 |
Previous close | 448.47 |
By Acuity
50%
50%
149 / 371 Healthcare
By Trading Central
Confidence
Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 460.22 USD -0.09%
High 583 USD
Low 290 USD
Based on 27 Wall Street analysts offering 12 month price targets forAlnylam Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$